Cocrystal Pharma (COCP) Depreciation and Depletion (2010 - 2023)
Cocrystal Pharma (COCP) reported Depreciation and Depletion of -$158000.0 for Q3 2023, down 4050.0% on a YoY basis from $4000.0 in Q3 2022, and down 235.04% sequentially from $117000.0 in Q2 2023.
Cocrystal Pharma (COCP) Depreciation and Depletion (2010 - 2023) Analysis & Trends
Cocrystal Pharma (COCP) has 10 years of Depreciation and Depletion data on file, last reported at -$158000.0 in Q3 2023.
- For the quarter ending Q3 2023, Depreciation and Depletion fell 4050.0% year-over-year to -$158000.0; the trailing twelve-month figure through Sep 2023 stood at $8000.0 (down 66.67% YoY), and the FY2018 full-year result was $50000.0, down 50.5% from the prior year.
- Depreciation and Depletion fell to -$158000.0 in Q3 2023, from $117000.0 in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $117000.0 in Q2 2023 to a low of -$158000.0 in Q3 2023.
- A 5-year average of $8857.1 and a median of $12000.0 in 2019 frame the typical range for Depreciation and Depletion.
- Peak annual rise in Depreciation and Depletion reached 2825.0% in 2023, while the deepest fall reached 4050.0% in 2023.
- Tracing COCP's Depreciation and Depletion over 5 years: stood at $17000.0 in 2019, then sank by 64.71% to $6000.0 in 2020, then surged by 100.0% to $12000.0 in 2021, then tumbled by 66.67% to $4000.0 in 2022, then slumped by 4050.0% to -$158000.0 in 2023.
- Business Quant data shows COCP's Depreciation and Depletion at -$158000.0 in Q3 2023, $117000.0 in Q2 2023, and $45000.0 in Q1 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 39.39 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 2.20 Mn |
| 10 | Cocrystal Pharma | 12.57 Mn | 7.74 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -158,000.00 |
| Sep 30, 2023 | -158,000.00 |
| Jun 30, 2023 | 117,000.00 |
| Jun 30, 2023 | 117,000.00 |
| Mar 31, 2023 | 45,000.00 |
| Mar 31, 2023 | 45,000.00 |
| Sep 30, 2022 | 4,000.00 |
| Sep 30, 2022 | 4,000.00 |
| Jun 30, 2022 | 4,000.00 |
| Jun 30, 2022 | 4,000.00 |
| Mar 31, 2022 | 4,000.00 |
| Mar 31, 2022 | 4,000.00 |
| Sep 30, 2021 | 12,000.00 |
| Sep 30, 2021 | 12,000.00 |
| Mar 31, 2021 | 6,000.00 |
| Mar 31, 2021 | 6,000.00 |
| Sep 30, 2020 | 6,000.00 |
| Sep 30, 2020 | 6,000.00 |
| Jun 30, 2020 | 15,000.00 |
| Jun 30, 2020 | 15,000.00 |